nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—DDR1—nipple—uterine fibroid	0.0143	0.0206	CbGeAlD
Imatinib—ABCA3—myometrium—uterine fibroid	0.0133	0.0191	CbGeAlD
Imatinib—NTRK1—decidua—uterine fibroid	0.0125	0.0179	CbGeAlD
Imatinib—DDR1—myometrium—uterine fibroid	0.0123	0.0177	CbGeAlD
Imatinib—ABCA3—decidua—uterine fibroid	0.00987	0.0142	CbGeAlD
Imatinib—DDR1—uterine cervix—uterine fibroid	0.00956	0.0137	CbGeAlD
Imatinib—ABCA3—urethra—uterine fibroid	0.00952	0.0137	CbGeAlD
Imatinib—ABCA3—endometrium—uterine fibroid	0.00937	0.0135	CbGeAlD
Imatinib—DDR1—smooth muscle tissue—uterine fibroid	0.00929	0.0134	CbGeAlD
Imatinib—DDR1—decidua—uterine fibroid	0.00911	0.0131	CbGeAlD
Imatinib—ABCA3—mammalian vulva—uterine fibroid	0.00906	0.013	CbGeAlD
Imatinib—PIP4K2C—nipple—uterine fibroid	0.00884	0.0127	CbGeAlD
Imatinib—DDR1—urethra—uterine fibroid	0.00878	0.0126	CbGeAlD
Imatinib—DDR1—endometrium—uterine fibroid	0.00864	0.0124	CbGeAlD
Imatinib—DDR1—mammalian vulva—uterine fibroid	0.00836	0.012	CbGeAlD
Imatinib—DDR1—cardiac atrium—uterine fibroid	0.00801	0.0115	CbGeAlD
Imatinib—DDR1—uterus—uterine fibroid	0.00797	0.0115	CbGeAlD
Imatinib—HIPK4—female reproductive system—uterine fibroid	0.00785	0.0113	CbGeAlD
Imatinib—LCK—nipple—uterine fibroid	0.00784	0.0113	CbGeAlD
Imatinib—PIP4K2C—myometrium—uterine fibroid	0.00758	0.0109	CbGeAlD
Imatinib—CA3—myometrium—uterine fibroid	0.00724	0.0104	CbGeAlD
Imatinib—ABCA3—female gonad—uterine fibroid	0.00706	0.0101	CbGeAlD
Imatinib—ABCA3—vagina—uterine fibroid	0.00702	0.0101	CbGeAlD
Imatinib—DDR1—female gonad—uterine fibroid	0.00652	0.00937	CbGeAlD
Imatinib—NQO2—nipple—uterine fibroid	0.00649	0.00933	CbGeAlD
Imatinib—DDR1—vagina—uterine fibroid	0.00648	0.00931	CbGeAlD
Imatinib—PTGS1—oviduct—uterine fibroid	0.00635	0.00913	CbGeAlD
Imatinib—PIP4K2C—uterine cervix—uterine fibroid	0.0059	0.00848	CbGeAlD
Imatinib—CSF1R—nipple—uterine fibroid	0.0057	0.00819	CbGeAlD
Imatinib—CA3—uterine cervix—uterine fibroid	0.00563	0.0081	CbGeAlD
Imatinib—PIP4K2C—decidua—uterine fibroid	0.00562	0.00808	CbGeAlD
Imatinib—NQO2—myometrium—uterine fibroid	0.00557	0.008	CbGeAlD
Imatinib—PIP4K2C—urethra—uterine fibroid	0.00542	0.00779	CbGeAlD
Imatinib—PIP4K2C—endometrium—uterine fibroid	0.00534	0.00767	CbGeAlD
Imatinib—LCK—uterine cervix—uterine fibroid	0.00524	0.00753	CbGeAlD
Imatinib—SLC47A1—nipple—uterine fibroid	0.00521	0.00748	CbGeAlD
Imatinib—KIT—nipple—uterine fibroid	0.00518	0.00744	CbGeAlD
Imatinib—PIP4K2C—mammalian vulva—uterine fibroid	0.00516	0.00742	CbGeAlD
Imatinib—PDGFRB—nipple—uterine fibroid	0.00506	0.00727	CbGeAlD
Imatinib—LCK—decidua—uterine fibroid	0.00499	0.00717	CbGeAlD
Imatinib—PIP4K2C—cardiac atrium—uterine fibroid	0.00494	0.00711	CbGeAlD
Imatinib—CSF1R—myometrium—uterine fibroid	0.00489	0.00703	CbGeAlD
Imatinib—LCK—urethra—uterine fibroid	0.00481	0.00692	CbGeAlD
Imatinib—CA3—cardiac atrium—uterine fibroid	0.00472	0.00678	CbGeAlD
Imatinib—CA3—uterus—uterine fibroid	0.0047	0.00675	CbGeAlD
Imatinib—LCK—mammalian vulva—uterine fibroid	0.00458	0.00659	CbGeAlD
Imatinib—ABL1—nipple—uterine fibroid	0.00451	0.00648	CbGeAlD
Imatinib—SLC47A1—myometrium—uterine fibroid	0.00447	0.00642	CbGeAlD
Imatinib—KIT—myometrium—uterine fibroid	0.00444	0.00638	CbGeAlD
Imatinib—PIP4K2C—female reproductive system—uterine fibroid	0.00442	0.00635	CbGeAlD
Imatinib—LCK—uterus—uterine fibroid	0.00436	0.00627	CbGeAlD
Imatinib—PDGFRB—myometrium—uterine fibroid	0.00434	0.00623	CbGeAlD
Imatinib—NQO2—uterine cervix—uterine fibroid	0.00433	0.00623	CbGeAlD
Imatinib—CA14—cardiac atrium—uterine fibroid	0.00429	0.00616	CbGeAlD
Imatinib—ABL2—female gonad—uterine fibroid	0.00425	0.00611	CbGeAlD
Imatinib—ABL2—vagina—uterine fibroid	0.00423	0.00607	CbGeAlD
Imatinib—PTGS1—artery—uterine fibroid	0.00421	0.00605	CbGeAlD
Imatinib—PDGFRA—smooth muscle tissue—uterine fibroid	0.0042	0.00604	CbGeAlD
Imatinib—NQO2—decidua—uterine fibroid	0.00413	0.00593	CbGeAlD
Imatinib—PDGFRA—decidua—uterine fibroid	0.00412	0.00592	CbGeAlD
Imatinib—CA9—female reproductive system—uterine fibroid	0.00404	0.00581	CbGeAlD
Imatinib—PIP4K2C—female gonad—uterine fibroid	0.00402	0.00578	CbGeAlD
Imatinib—PIP4K2C—vagina—uterine fibroid	0.004	0.00575	CbGeAlD
Imatinib—NQO2—urethra—uterine fibroid	0.00398	0.00572	CbGeAlD
Imatinib—NQO2—endometrium—uterine fibroid	0.00392	0.00563	CbGeAlD
Imatinib—ABL1—myometrium—uterine fibroid	0.00387	0.00556	CbGeAlD
Imatinib—CA3—vagina—uterine fibroid	0.00382	0.00549	CbGeAlD
Imatinib—CSF1R—uterine cervix—uterine fibroid	0.00381	0.00547	CbGeAlD
Imatinib—NQO2—mammalian vulva—uterine fibroid	0.00379	0.00545	CbGeAlD
Imatinib—CSF1R—smooth muscle tissue—uterine fibroid	0.0037	0.00532	CbGeAlD
Imatinib—NQO2—cardiac atrium—uterine fibroid	0.00363	0.00522	CbGeAlD
Imatinib—CSF1R—decidua—uterine fibroid	0.00363	0.00521	CbGeAlD
Imatinib—NQO2—uterus—uterine fibroid	0.00361	0.00519	CbGeAlD
Imatinib—PDGFRA—uterus—uterine fibroid	0.0036	0.00518	CbGeAlD
Imatinib—LCK—female gonad—uterine fibroid	0.00357	0.00513	CbGeAlD
Imatinib—LCK—vagina—uterine fibroid	0.00355	0.0051	CbGeAlD
Imatinib—CSF1R—urethra—uterine fibroid	0.0035	0.00503	CbGeAlD
Imatinib—SLC47A1—uterine cervix—uterine fibroid	0.00348	0.005	CbGeAlD
Imatinib—KIT—uterine cervix—uterine fibroid	0.00346	0.00497	CbGeAlD
Imatinib—CSF1R—endometrium—uterine fibroid	0.00344	0.00495	CbGeAlD
Imatinib—PDGFRB—uterine cervix—uterine fibroid	0.00337	0.00485	CbGeAlD
Imatinib—KIT—smooth muscle tissue—uterine fibroid	0.00336	0.00483	CbGeAlD
Imatinib—CSF1R—mammalian vulva—uterine fibroid	0.00333	0.00479	CbGeAlD
Imatinib—SLC47A1—decidua—uterine fibroid	0.00331	0.00476	CbGeAlD
Imatinib—KIT—decidua—uterine fibroid	0.00329	0.00473	CbGeAlD
Imatinib—PDGFRB—smooth muscle tissue—uterine fibroid	0.00328	0.00471	CbGeAlD
Imatinib—NQO2—female reproductive system—uterine fibroid	0.00325	0.00467	CbGeAlD
Imatinib—PDGFRA—female reproductive system—uterine fibroid	0.00324	0.00465	CbGeAlD
Imatinib—PDGFRB—decidua—uterine fibroid	0.00322	0.00462	CbGeAlD
Imatinib—SLC47A1—urethra—uterine fibroid	0.00319	0.00459	CbGeAlD
Imatinib—CSF1R—cardiac atrium—uterine fibroid	0.00319	0.00458	CbGeAlD
Imatinib—KIT—urethra—uterine fibroid	0.00318	0.00456	CbGeAlD
Imatinib—CSF1R—uterus—uterine fibroid	0.00317	0.00456	CbGeAlD
Imatinib—SLC47A1—endometrium—uterine fibroid	0.00314	0.00452	CbGeAlD
Imatinib—KIT—endometrium—uterine fibroid	0.00313	0.00449	CbGeAlD
Imatinib—PDGFRB—urethra—uterine fibroid	0.0031	0.00446	CbGeAlD
Imatinib—CA2—nipple—uterine fibroid	0.00307	0.00441	CbGeAlD
Imatinib—PDGFRB—endometrium—uterine fibroid	0.00305	0.00439	CbGeAlD
Imatinib—SLC47A1—mammalian vulva—uterine fibroid	0.00304	0.00437	CbGeAlD
Imatinib—KIT—mammalian vulva—uterine fibroid	0.00302	0.00435	CbGeAlD
Imatinib—ABL1—uterine cervix—uterine fibroid	0.00301	0.00432	CbGeAlD
Imatinib—CA12—female reproductive system—uterine fibroid	0.00299	0.0043	CbGeAlD
Imatinib—NQO2—female gonad—uterine fibroid	0.00295	0.00425	CbGeAlD
Imatinib—PDGFRB—mammalian vulva—uterine fibroid	0.00295	0.00424	CbGeAlD
Imatinib—PDGFRA—female gonad—uterine fibroid	0.00295	0.00424	CbGeAlD
Imatinib—NQO2—vagina—uterine fibroid	0.00294	0.00422	CbGeAlD
Imatinib—PDGFRA—vagina—uterine fibroid	0.00293	0.00421	CbGeAlD
Imatinib—ABL1—smooth muscle tissue—uterine fibroid	0.00292	0.0042	CbGeAlD
Imatinib—SLC47A1—uterus—uterine fibroid	0.0029	0.00416	CbGeAlD
Imatinib—KIT—uterus—uterine fibroid	0.00288	0.00414	CbGeAlD
Imatinib—ABL1—decidua—uterine fibroid	0.00287	0.00412	CbGeAlD
Imatinib—ORM1—endometrium—uterine fibroid	0.00286	0.00412	CbGeAlD
Imatinib—CSF1R—female reproductive system—uterine fibroid	0.00285	0.0041	CbGeAlD
Imatinib—PDGFRB—cardiac atrium—uterine fibroid	0.00283	0.00406	CbGeAlD
Imatinib—PDGFRB—uterus—uterine fibroid	0.00281	0.00404	CbGeAlD
Imatinib—ABL1—urethra—uterine fibroid	0.00276	0.00397	CbGeAlD
Imatinib—CYP1A2—nipple—uterine fibroid	0.00273	0.00393	CbGeAlD
Imatinib—ABL1—endometrium—uterine fibroid	0.00272	0.00391	CbGeAlD
Imatinib—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00269	0.00884	CbGpPWpGaD
Imatinib—KIT—GAB1 signalosome—TNRC6B—uterine fibroid	0.00268	0.00879	CbGpPWpGaD
Imatinib—CYP3A7—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00265	0.00872	CbGpPWpGaD
Imatinib—ABL1—mammalian vulva—uterine fibroid	0.00263	0.00378	CbGeAlD
Imatinib—PDGFRA—PI-3K cascade—TNRC6B—uterine fibroid	0.00262	0.0086	CbGpPWpGaD
Imatinib—KIT—Role of LAT2/NTAL/LAB on calcium mobilization—TNRC6B—uterine fibroid	0.00262	0.00859	CbGpPWpGaD
Imatinib—SLC47A1—female reproductive system—uterine fibroid	0.0026	0.00374	CbGeAlD
Imatinib—CSF1R—female gonad—uterine fibroid	0.00259	0.00373	CbGeAlD
Imatinib—KIT—female reproductive system—uterine fibroid	0.00259	0.00372	CbGeAlD
Imatinib—CSF1R—vagina—uterine fibroid	0.00258	0.00371	CbGeAlD
Imatinib—PDGFRA—PI3K/AKT activation—TNRC6B—uterine fibroid	0.00255	0.00839	CbGpPWpGaD
Imatinib—PDGFRA—GAB1 signalosome—TNRC6B—uterine fibroid	0.00253	0.00832	CbGpPWpGaD
Imatinib—PDGFRB—female reproductive system—uterine fibroid	0.00253	0.00363	CbGeAlD
Imatinib—ABL1—cardiac atrium—uterine fibroid	0.00252	0.00362	CbGeAlD
Imatinib—ABL1—uterus—uterine fibroid	0.00251	0.0036	CbGeAlD
Imatinib—PDGFRA—Role of LAT2/NTAL/LAB on calcium mobilization—TNRC6B—uterine fibroid	0.00248	0.00813	CbGpPWpGaD
Imatinib—ABCG2—myometrium—uterine fibroid	0.00244	0.0035	CbGeAlD
Imatinib—ORM1—female reproductive system—uterine fibroid	0.00237	0.00341	CbGeAlD
Imatinib—PTGS1—nipple—uterine fibroid	0.00237	0.00341	CbGeAlD
Imatinib—SLC47A1—female gonad—uterine fibroid	0.00237	0.00341	CbGeAlD
Imatinib—CA1—female reproductive system—uterine fibroid	0.00237	0.0034	CbGeAlD
Imatinib—PDGFRB—PI-3K cascade—TNRC6B—uterine fibroid	0.00236	0.00774	CbGpPWpGaD
Imatinib—KIT—female gonad—uterine fibroid	0.00236	0.00339	CbGeAlD
Imatinib—SLC47A1—vagina—uterine fibroid	0.00235	0.00339	CbGeAlD
Imatinib—KIT—vagina—uterine fibroid	0.00234	0.00337	CbGeAlD
Imatinib—PDGFRB—female gonad—uterine fibroid	0.0023	0.00331	CbGeAlD
Imatinib—PDGFRB—PI3K/AKT activation—TNRC6B—uterine fibroid	0.0023	0.00756	CbGpPWpGaD
Imatinib—PDGFRB—vagina—uterine fibroid	0.00229	0.00329	CbGeAlD
Imatinib—PDGFRB—GAB1 signalosome—TNRC6B—uterine fibroid	0.00228	0.0075	CbGpPWpGaD
Imatinib—ABL1—female reproductive system—uterine fibroid	0.00225	0.00324	CbGeAlD
Imatinib—PDGFRB—Role of LAT2/NTAL/LAB on calcium mobilization—TNRC6B—uterine fibroid	0.00223	0.00733	CbGpPWpGaD
Imatinib—CYP3A7—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00218	0.00716	CbGpPWpGaD
Imatinib—ABL2—Developmental Biology—MED12—uterine fibroid	0.00213	0.007	CbGpPWpGaD
Imatinib—PTGS1—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00211	0.00694	CbGpPWpGaD
Imatinib—CYP1A2—Estrogen Receptor Pathway—ESR1—uterine fibroid	0.0021	0.00691	CbGpPWpGaD
Imatinib—NTRK1—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.00208	0.00684	CbGpPWpGaD
Imatinib—PDGFRA—ATF-2 transcription factor network—ESR1—uterine fibroid	0.00208	0.00682	CbGpPWpGaD
Imatinib—KIT—Signaling by SCF-KIT—TNRC6B—uterine fibroid	0.00207	0.00679	CbGpPWpGaD
Imatinib—ABL1—female gonad—uterine fibroid	0.00205	0.00295	CbGeAlD
Imatinib—ABL1—vagina—uterine fibroid	0.00204	0.00293	CbGeAlD
Imatinib—CA14—Metabolism—HPSE2—uterine fibroid	0.00203	0.00667	CbGpPWpGaD
Imatinib—CA2—smooth muscle tissue—uterine fibroid	0.00199	0.00286	CbGeAlD
Imatinib—CA6—Metabolism—HPSE2—uterine fibroid	0.00198	0.0065	CbGpPWpGaD
Imatinib—KIT—Downstream signaling of activated FGFR—TNRC6B—uterine fibroid	0.00198	0.00649	CbGpPWpGaD
Imatinib—SLC22A1—vagina—uterine fibroid	0.00196	0.00282	CbGeAlD
Imatinib—PDGFRA—Signaling by SCF-KIT—TNRC6B—uterine fibroid	0.00196	0.00643	CbGpPWpGaD
Imatinib—CA2—decidua—uterine fibroid	0.00195	0.00281	CbGeAlD
Imatinib—KIT—Signaling by ERBB4—TNRC6B—uterine fibroid	0.00195	0.00639	CbGpPWpGaD
Imatinib—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00194	0.00639	CbGpPWpGaD
Imatinib—KIT—Signaling by ERBB4—PGR—uterine fibroid	0.00193	0.00633	CbGpPWpGaD
Imatinib—CYP3A5—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00192	0.0063	CbGpPWpGaD
Imatinib—ABCG2—uterine cervix—uterine fibroid	0.0019	0.00273	CbGeAlD
Imatinib—LCK—PI-3K cascade—TNRC6B—uterine fibroid	0.00189	0.00621	CbGpPWpGaD
Imatinib—PDGFRA—Downstream signaling of activated FGFR—TNRC6B—uterine fibroid	0.00187	0.00615	CbGpPWpGaD
Imatinib—KIT—Downstream signal transduction—TNRC6B—uterine fibroid	0.00186	0.0061	CbGpPWpGaD
Imatinib—KIT—Signaling by FGFR—TNRC6B—uterine fibroid	0.00185	0.00607	CbGpPWpGaD
Imatinib—CA7—Metabolism—HPSE2—uterine fibroid	0.00185	0.00607	CbGpPWpGaD
Imatinib—LCK—PI3K/AKT activation—TNRC6B—uterine fibroid	0.00185	0.00607	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by ERBB4—TNRC6B—uterine fibroid	0.00184	0.00605	CbGpPWpGaD
Imatinib—KIT—Signaling by ERBB2—TNRC6B—uterine fibroid	0.00184	0.00604	CbGpPWpGaD
Imatinib—LCK—GAB1 signalosome—TNRC6B—uterine fibroid	0.00183	0.00602	CbGpPWpGaD
Imatinib—KIT—DAP12 signaling—TNRC6B—uterine fibroid	0.00183	0.00601	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by ERBB4—PGR—uterine fibroid	0.00182	0.00599	CbGpPWpGaD
Imatinib—ABCG2—decidua—uterine fibroid	0.00181	0.0026	CbGeAlD
Imatinib—KIT—Downstream signaling events of B Cell Receptor (BCR)—TNRC6B—uterine fibroid	0.0018	0.00593	CbGpPWpGaD
Imatinib—CA2—mammalian vulva—uterine fibroid	0.00179	0.00258	CbGeAlD
Imatinib—LCK—Role of LAT2/NTAL/LAB on calcium mobilization—TNRC6B—uterine fibroid	0.00179	0.00588	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by SCF-KIT—TNRC6B—uterine fibroid	0.00176	0.00579	CbGpPWpGaD
Imatinib—CYP3A5—uterine cervix—uterine fibroid	0.00176	0.00253	CbGeAlD
Imatinib—PDGFRA—Downstream signal transduction—TNRC6B—uterine fibroid	0.00176	0.00578	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by FGFR—TNRC6B—uterine fibroid	0.00175	0.00575	CbGpPWpGaD
Imatinib—ABCG2—urethra—uterine fibroid	0.00174	0.00251	CbGeAlD
Imatinib—PDGFRA—Signaling by ERBB2—TNRC6B—uterine fibroid	0.00174	0.00572	CbGpPWpGaD
Imatinib—PDGFRA—DAP12 signaling—TNRC6B—uterine fibroid	0.00173	0.00569	CbGpPWpGaD
Imatinib—KIT—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.00172	0.00566	CbGpPWpGaD
Imatinib—KIT—DAP12 interactions—TNRC6B—uterine fibroid	0.00172	0.00566	CbGpPWpGaD
Imatinib—KIT—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.00172	0.00566	CbGpPWpGaD
Imatinib—CA2—cardiac atrium—uterine fibroid	0.00172	0.00247	CbGeAlD
Imatinib—ABCG2—endometrium—uterine fibroid	0.00172	0.00247	CbGeAlD
Imatinib—CA12—Metabolism—HPSE2—uterine fibroid	0.00171	0.00562	CbGpPWpGaD
Imatinib—PDGFRA—Downstream signaling events of B Cell Receptor (BCR)—TNRC6B—uterine fibroid	0.00171	0.00561	CbGpPWpGaD
Imatinib—KIT—Signaling by EGFR—TNRC6B—uterine fibroid	0.00171	0.00561	CbGpPWpGaD
Imatinib—KIT—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.00169	0.00556	CbGpPWpGaD
Imatinib—PDGFRB—Downstream signaling of activated FGFR—TNRC6B—uterine fibroid	0.00169	0.00554	CbGpPWpGaD
Imatinib—KIT—Signaling by PDGF—TNRC6B—uterine fibroid	0.00168	0.00553	CbGpPWpGaD
Imatinib—ABCG2—mammalian vulva—uterine fibroid	0.00166	0.00239	CbGeAlD
Imatinib—PDGFRB—Signaling by ERBB4—TNRC6B—uterine fibroid	0.00166	0.00545	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by ERBB4—PGR—uterine fibroid	0.00164	0.0054	CbGpPWpGaD
Imatinib—CA9—Cellular responses to stress—TNRC6B—uterine fibroid	0.00164	0.00539	CbGpPWpGaD
Imatinib—PDGFRA—DAP12 interactions—TNRC6B—uterine fibroid	0.00163	0.00536	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.00163	0.00536	CbGpPWpGaD
Imatinib—PDGFRA—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.00163	0.00536	CbGpPWpGaD
Imatinib—ABL1—Regulation of Telomerase—ESR1—uterine fibroid	0.00163	0.00534	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by EGFR—TNRC6B—uterine fibroid	0.00162	0.00531	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.0016	0.00526	CbGpPWpGaD
Imatinib—NTRK1—Signaling by NGF—TNRC6B—uterine fibroid	0.0016	0.00526	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by PDGF—TNRC6B—uterine fibroid	0.00159	0.00524	CbGpPWpGaD
Imatinib—KIT—B Cell Activation—TNRC6B—uterine fibroid	0.00159	0.00524	CbGpPWpGaD
Imatinib—PDGFRB—Downstream signal transduction—TNRC6B—uterine fibroid	0.00158	0.00521	CbGpPWpGaD
Imatinib—PTGS1—uterine cervix—uterine fibroid	0.00158	0.00227	CbGeAlD
Imatinib—ABCG2—uterus—uterine fibroid	0.00158	0.00227	CbGeAlD
Imatinib—PDGFRB—Signaling by FGFR—TNRC6B—uterine fibroid	0.00158	0.00518	CbGpPWpGaD
Imatinib—CYP3A5—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00158	0.00518	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by ERBB2—TNRC6B—uterine fibroid	0.00157	0.00515	CbGpPWpGaD
Imatinib—PDGFRB—DAP12 signaling—TNRC6B—uterine fibroid	0.00156	0.00513	CbGpPWpGaD
Imatinib—PDGFRB—Downstream signaling events of B Cell Receptor (BCR)—TNRC6B—uterine fibroid	0.00154	0.00506	CbGpPWpGaD
Imatinib—PTGS1—smooth muscle tissue—uterine fibroid	0.00154	0.00221	CbGeAlD
Imatinib—CA2—female reproductive system—uterine fibroid	0.00153	0.00221	CbGeAlD
Imatinib—KIT—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.00153	0.00501	CbGpPWpGaD
Imatinib—CYP2C19—vagina—uterine fibroid	0.00151	0.00218	CbGeAlD
Imatinib—PDGFRA—B Cell Activation—TNRC6B—uterine fibroid	0.00151	0.00496	CbGpPWpGaD
Imatinib—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.0015	0.00494	CbGpPWpGaD
Imatinib—CYP2C19—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00148	0.00487	CbGpPWpGaD
Imatinib—PDGFRB—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.00147	0.00483	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.00147	0.00483	CbGpPWpGaD
Imatinib—PDGFRB—DAP12 interactions—TNRC6B—uterine fibroid	0.00147	0.00483	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by EGFR—TNRC6B—uterine fibroid	0.00146	0.00478	CbGpPWpGaD
Imatinib—PDGFRA—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.00144	0.00474	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.00144	0.00474	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by PDGF—TNRC6B—uterine fibroid	0.00144	0.00472	CbGpPWpGaD
Imatinib—PTGS1—endometrium—uterine fibroid	0.00143	0.00206	CbGeAlD
Imatinib—LCK—Signaling by SCF-KIT—TNRC6B—uterine fibroid	0.00141	0.00465	CbGpPWpGaD
Imatinib—CA2—female gonad—uterine fibroid	0.0014	0.00201	CbGeAlD
Imatinib—CA2—vagina—uterine fibroid	0.00139	0.002	CbGeAlD
Imatinib—PTGS1—mammalian vulva—uterine fibroid	0.00138	0.00199	CbGeAlD
Imatinib—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00138	0.00454	CbGpPWpGaD
Imatinib—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00137	0.0045	CbGpPWpGaD
Imatinib—CYP2D6—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00136	0.00448	CbGpPWpGaD
Imatinib—PDGFRB—B Cell Activation—TNRC6B—uterine fibroid	0.00136	0.00447	CbGpPWpGaD
Imatinib—LCK—Downstream signaling of activated FGFR—TNRC6B—uterine fibroid	0.00135	0.00444	CbGpPWpGaD
Imatinib—CYP2C9—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00135	0.00444	CbGpPWpGaD
Imatinib—CA3—Metabolism—MED12—uterine fibroid	0.00135	0.00443	CbGpPWpGaD
Imatinib—LCK—Signaling by ERBB4—TNRC6B—uterine fibroid	0.00133	0.00437	CbGpPWpGaD
Imatinib—PTGS1—cardiac atrium—uterine fibroid	0.00133	0.00191	CbGeAlD
Imatinib—PTGS1—uterus—uterine fibroid	0.00132	0.0019	CbGeAlD
Imatinib—LCK—Signaling by ERBB4—PGR—uterine fibroid	0.00132	0.00433	CbGpPWpGaD
Imatinib—CA2—Metabolism—HPSE2—uterine fibroid	0.00131	0.0043	CbGpPWpGaD
Imatinib—PDGFRB—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.0013	0.00427	CbGpPWpGaD
Imatinib—CYP2C9—female reproductive system—uterine fibroid	0.0013	0.00187	CbGeAlD
Imatinib—ABCG2—female gonad—uterine fibroid	0.00129	0.00186	CbGeAlD
Imatinib—ABCG2—vagina—uterine fibroid	0.00129	0.00185	CbGeAlD
Imatinib—LCK—Downstream signal transduction—TNRC6B—uterine fibroid	0.00127	0.00418	CbGpPWpGaD
Imatinib—LCK—Signaling by FGFR—TNRC6B—uterine fibroid	0.00127	0.00416	CbGpPWpGaD
Imatinib—LCK—Signaling by ERBB2—TNRC6B—uterine fibroid	0.00126	0.00414	CbGpPWpGaD
Imatinib—CA1—Metabolism—HPSE2—uterine fibroid	0.00125	0.00412	CbGpPWpGaD
Imatinib—LCK—DAP12 signaling—TNRC6B—uterine fibroid	0.00125	0.00412	CbGpPWpGaD
Imatinib—LCK—Downstream signaling events of B Cell Receptor (BCR)—TNRC6B—uterine fibroid	0.00123	0.00406	CbGpPWpGaD
Imatinib—CYP2C19—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00122	0.004	CbGpPWpGaD
Imatinib—ABCB1—myometrium—uterine fibroid	0.0012	0.00173	CbGeAlD
Imatinib—CYP3A5—female gonad—uterine fibroid	0.0012	0.00173	CbGeAlD
Imatinib—CYP3A5—vagina—uterine fibroid	0.00119	0.00172	CbGeAlD
Imatinib—PTGS1—female reproductive system—uterine fibroid	0.00119	0.0017	CbGeAlD
Imatinib—LCK—DAP12 interactions—TNRC6B—uterine fibroid	0.00118	0.00387	CbGpPWpGaD
Imatinib—LCK—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.00118	0.00387	CbGpPWpGaD
Imatinib—LCK—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.00118	0.00387	CbGpPWpGaD
Imatinib—KIT—Signaling by NGF—TNRC6B—uterine fibroid	0.00117	0.00385	CbGpPWpGaD
Imatinib—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00117	0.00385	CbGpPWpGaD
Imatinib—NTRK1—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.00117	0.00384	CbGpPWpGaD
Imatinib—LCK—Signaling by EGFR—TNRC6B—uterine fibroid	0.00117	0.00384	CbGpPWpGaD
Imatinib—CYP3A7—Biological oxidations—CYP17A1—uterine fibroid	0.00116	0.0038	CbGpPWpGaD
Imatinib—LCK—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.00116	0.0038	CbGpPWpGaD
Imatinib—CYP1A2—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00116	0.0038	CbGpPWpGaD
Imatinib—LCK—Signaling by PDGF—TNRC6B—uterine fibroid	0.00115	0.00379	CbGpPWpGaD
Imatinib—CYP3A7—Metapathway biotransformation—CYP17A1—uterine fibroid	0.00114	0.00375	CbGpPWpGaD
Imatinib—CA3—Metabolism—CYP17A1—uterine fibroid	0.00113	0.00371	CbGpPWpGaD
Imatinib—PTGS1—Biological oxidations—CYP17A1—uterine fibroid	0.00112	0.00369	CbGpPWpGaD
Imatinib—CYP2D6—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00112	0.00368	CbGpPWpGaD
Imatinib—CYP2C9—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00111	0.00365	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by NGF—TNRC6B—uterine fibroid	0.00111	0.00365	CbGpPWpGaD
Imatinib—CA9—Metabolism—HPSE2—uterine fibroid	0.0011	0.00362	CbGpPWpGaD
Imatinib—LCK—B Cell Activation—TNRC6B—uterine fibroid	0.00109	0.00358	CbGpPWpGaD
Imatinib—PTGS1—female gonad—uterine fibroid	0.00108	0.00155	CbGeAlD
Imatinib—PTGS1—vagina—uterine fibroid	0.00107	0.00154	CbGeAlD
Imatinib—LCK—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.00104	0.00343	CbGpPWpGaD
Imatinib—KIT—Signaling by ERBB4—ESR1—uterine fibroid	0.00103	0.00338	CbGpPWpGaD
Imatinib—KIT—Disease—HPSE2—uterine fibroid	0.001	0.0033	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by NGF—TNRC6B—uterine fibroid	0.001	0.00329	CbGpPWpGaD
Imatinib—CYP3A4—female reproductive system—uterine fibroid	0.00099	0.00142	CbGeAlD
Imatinib—CYP2D6—female reproductive system—uterine fibroid	0.000974	0.0014	CbGeAlD
Imatinib—PDGFRA—Signaling by ERBB4—ESR1—uterine fibroid	0.000973	0.0032	CbGpPWpGaD
Imatinib—PDGFRA—Disease—HPSE2—uterine fibroid	0.00095	0.00312	CbGpPWpGaD
Imatinib—CYP1A2—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000949	0.00312	CbGpPWpGaD
Imatinib—ABCB1—uterine cervix—uterine fibroid	0.000935	0.00134	CbGeAlD
Imatinib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.000904	0.00297	CbGpPWpGaD
Imatinib—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.000892	0.00293	CbGpPWpGaD
Imatinib—ABCB1—decidua—uterine fibroid	0.000891	0.00128	CbGeAlD
Imatinib—CYP2D6—female gonad—uterine fibroid	0.000886	0.00127	CbGeAlD
Imatinib—PDGFRB—Signaling by ERBB4—ESR1—uterine fibroid	0.000877	0.00288	CbGpPWpGaD
Imatinib—CA14—Metabolism—MED12—uterine fibroid	0.00087	0.00286	CbGpPWpGaD
Imatinib—ABCB1—urethra—uterine fibroid	0.00086	0.00124	CbGeAlD
Imatinib—ABL1—Integrated Breast Cancer Pathway—ESR1—uterine fibroid	0.000859	0.00282	CbGpPWpGaD
Imatinib—PDGFRB—Disease—HPSE2—uterine fibroid	0.000856	0.00281	CbGpPWpGaD
Imatinib—CA6—Metabolism—MED12—uterine fibroid	0.000847	0.00278	CbGpPWpGaD
Imatinib—ABCB1—endometrium—uterine fibroid	0.000846	0.00122	CbGeAlD
Imatinib—CYP3A5—Biological oxidations—CYP17A1—uterine fibroid	0.000837	0.00275	CbGpPWpGaD
Imatinib—CYP3A5—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000826	0.00271	CbGpPWpGaD
Imatinib—ABCB1—mammalian vulva—uterine fibroid	0.000818	0.00118	CbGeAlD
Imatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.000811	0.00266	CbGpPWpGaD
Imatinib—LCK—Signaling by NGF—TNRC6B—uterine fibroid	0.000803	0.00264	CbGpPWpGaD
Imatinib—CA7—Metabolism—MED12—uterine fibroid	0.000791	0.0026	CbGpPWpGaD
Imatinib—ABCB1—uterus—uterine fibroid	0.00078	0.00112	CbGeAlD
Imatinib—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—uterine fibroid	0.000765	0.00252	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—MED12—uterine fibroid	0.000752	0.00247	CbGpPWpGaD
Imatinib—CA12—Metabolism—MED12—uterine fibroid	0.000733	0.00241	CbGpPWpGaD
Imatinib—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000733	0.00241	CbGpPWpGaD
Imatinib—CA14—Metabolism—CYP17A1—uterine fibroid	0.000728	0.00239	CbGpPWpGaD
Imatinib—ABL1—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.000712	0.00234	CbGpPWpGaD
Imatinib—CA6—Metabolism—CYP17A1—uterine fibroid	0.000709	0.00233	CbGpPWpGaD
Imatinib—LCK—Signaling by ERBB4—ESR1—uterine fibroid	0.000704	0.00231	CbGpPWpGaD
Imatinib—ABCB1—female reproductive system—uterine fibroid	0.000701	0.00101	CbGeAlD
Imatinib—LCK—Disease—HPSE2—uterine fibroid	0.000687	0.00226	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—TNRC6B—uterine fibroid	0.000669	0.0022	CbGpPWpGaD
Imatinib—CA7—Metabolism—CYP17A1—uterine fibroid	0.000662	0.00218	CbGpPWpGaD
Imatinib—CYP2C19—Biological oxidations—CYP17A1—uterine fibroid	0.000647	0.00213	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—TNRC6B—uterine fibroid	0.000643	0.00211	CbGpPWpGaD
Imatinib—CYP2C19—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000638	0.0021	CbGpPWpGaD
Imatinib—ABCB1—female gonad—uterine fibroid	0.000638	0.000917	CbGeAlD
Imatinib—ABCB1—vagina—uterine fibroid	0.000634	0.000911	CbGeAlD
Imatinib—PDGFRA—Innate Immune System—TNRC6B—uterine fibroid	0.000633	0.00208	CbGpPWpGaD
Imatinib—CA12—Metabolism—CYP17A1—uterine fibroid	0.000613	0.00202	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—TNRC6B—uterine fibroid	0.000608	0.002	CbGpPWpGaD
Imatinib—CYP2D6—Biological oxidations—CYP17A1—uterine fibroid	0.000595	0.00196	CbGpPWpGaD
Imatinib—CYP2C9—Biological oxidations—CYP17A1—uterine fibroid	0.00059	0.00194	CbGpPWpGaD
Imatinib—CYP2D6—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000587	0.00193	CbGpPWpGaD
Imatinib—CYP2C9—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000582	0.00191	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—TNRC6B—uterine fibroid	0.000571	0.00187	CbGpPWpGaD
Imatinib—CA2—Metabolism—MED12—uterine fibroid	0.00056	0.00184	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—HPSE2—uterine fibroid	0.000557	0.00183	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—TNRC6B—uterine fibroid	0.000556	0.00183	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—HPSE2—uterine fibroid	0.000552	0.00182	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—HPSE2—uterine fibroid	0.000552	0.00181	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—TNRC6B—uterine fibroid	0.000548	0.0018	CbGpPWpGaD
Imatinib—CA1—Metabolism—MED12—uterine fibroid	0.000537	0.00177	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—HPSE2—uterine fibroid	0.000535	0.00176	CbGpPWpGaD
Imatinib—PTGS1—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.000515	0.00169	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—HPSE2—uterine fibroid	0.000514	0.00169	CbGpPWpGaD
Imatinib—CYP1A2—Biological oxidations—CYP17A1—uterine fibroid	0.000504	0.00166	CbGpPWpGaD
Imatinib—CYP1A2—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000497	0.00163	CbGpPWpGaD
Imatinib—CA9—Metabolism—MED12—uterine fibroid	0.000472	0.00155	CbGpPWpGaD
Imatinib—CA2—Metabolism—CYP17A1—uterine fibroid	0.000469	0.00154	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—TNRC6B—uterine fibroid	0.000458	0.0015	CbGpPWpGaD
Imatinib—CA1—Metabolism—CYP17A1—uterine fibroid	0.00045	0.00148	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—TNRC6B—uterine fibroid	0.00044	0.00144	CbGpPWpGaD
Imatinib—PTGS1—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.000431	0.00142	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—HPSE2—uterine fibroid	0.000399	0.00131	CbGpPWpGaD
Imatinib—CA9—Metabolism—CYP17A1—uterine fibroid	0.000395	0.0013	CbGpPWpGaD
Imatinib—KIT—Immune System—TNRC6B—uterine fibroid	0.00039	0.00128	CbGpPWpGaD
Imatinib—CYP3A4—Biological oxidations—CYP17A1—uterine fibroid	0.000389	0.00128	CbGpPWpGaD
Imatinib—CYP3A4—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000384	0.00126	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—TNRC6B—uterine fibroid	0.000369	0.00121	CbGpPWpGaD
Imatinib—KIT—Disease—TNRC6B—uterine fibroid	0.00036	0.00118	CbGpPWpGaD
Imatinib—ALB—Metabolism—HPSE2—uterine fibroid	0.000344	0.00113	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—TNRC6B—uterine fibroid	0.000344	0.00113	CbGpPWpGaD
Imatinib—PDGFRA—Disease—TNRC6B—uterine fibroid	0.000341	0.00112	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—PGR—uterine fibroid	0.00034	0.00112	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—TNRC6B—uterine fibroid	0.000332	0.00109	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.000331	0.00109	CbGpPWpGaD
Imatinib—ABL1—Immune System—TNRC6B—uterine fibroid	0.000324	0.00106	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—HPSE2—uterine fibroid	0.000309	0.00101	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.000307	0.00101	CbGpPWpGaD
Imatinib—PDGFRB—Disease—TNRC6B—uterine fibroid	0.000307	0.00101	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—HPSE2—uterine fibroid	0.000301	0.00099	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.000297	0.000975	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—HPSE2—uterine fibroid	0.000284	0.000933	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—HPSE2—uterine fibroid	0.000282	0.000925	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.000277	0.00091	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.000271	0.000889	CbGpPWpGaD
Imatinib—LCK—Immune System—TNRC6B—uterine fibroid	0.000267	0.000876	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TNRC6B—uterine fibroid	0.000252	0.000828	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—PGR—uterine fibroid	0.000249	0.00082	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.000248	0.000816	CbGpPWpGaD
Imatinib—LCK—Disease—TNRC6B—uterine fibroid	0.000246	0.000809	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—HPSE2—uterine fibroid	0.000241	0.00079	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—MED12—uterine fibroid	0.000239	0.000784	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TNRC6B—uterine fibroid	0.000239	0.000784	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—MED12—uterine fibroid	0.000237	0.000777	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—MED12—uterine fibroid	0.000236	0.000776	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—PGR—uterine fibroid	0.000236	0.000776	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.000231	0.00076	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—MED12—uterine fibroid	0.000229	0.000753	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.000227	0.000744	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—MED12—uterine fibroid	0.00022	0.000723	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TNRC6B—uterine fibroid	0.000215	0.000706	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—PGR—uterine fibroid	0.000213	0.000699	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—CYP17A1—uterine fibroid	0.0002	0.000656	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—CYP17A1—uterine fibroid	0.000198	0.000651	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—CYP17A1—uterine fibroid	0.000198	0.00065	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.000194	0.000636	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—CYP17A1—uterine fibroid	0.000192	0.000631	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—HPSE2—uterine fibroid	0.000186	0.00061	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—CYP17A1—uterine fibroid	0.000184	0.000606	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—ESR1—uterine fibroid	0.000182	0.000597	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TNRC6B—uterine fibroid	0.000172	0.000567	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—MED12—uterine fibroid	0.000171	0.000562	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—PGR—uterine fibroid	0.000171	0.000561	CbGpPWpGaD
Imatinib—ALB—Metabolism—MED12—uterine fibroid	0.000147	0.000484	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—CYP17A1—uterine fibroid	0.000143	0.00047	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—ESR1—uterine fibroid	0.000133	0.000438	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—MED12—uterine fibroid	0.000132	0.000434	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—MED12—uterine fibroid	0.000129	0.000424	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—ESR1—uterine fibroid	0.000126	0.000414	CbGpPWpGaD
Imatinib—ALB—Metabolism—CYP17A1—uterine fibroid	0.000123	0.000405	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—MED12—uterine fibroid	0.000122	0.0004	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—MED12—uterine fibroid	0.000121	0.000396	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—ESR1—uterine fibroid	0.000114	0.000373	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—CYP17A1—uterine fibroid	0.000111	0.000364	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—CYP17A1—uterine fibroid	0.000108	0.000355	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—MED12—uterine fibroid	0.000103	0.000338	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—CYP17A1—uterine fibroid	0.000102	0.000334	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—CYP17A1—uterine fibroid	0.000101	0.000332	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—ESR1—uterine fibroid	9.11e-05	0.000299	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CYP17A1—uterine fibroid	8.62e-05	0.000283	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—MED12—uterine fibroid	7.95e-05	0.000261	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CYP17A1—uterine fibroid	6.65e-05	0.000219	CbGpPWpGaD
